Company intelligence / Profile preview
Turn Therapeutics
Calabasas/Westlake Village, California, United Statesturntherapeutics.com ↗
- Ownership
- Public · TTRX
- Employees
- ~7
- Development stage
- Commercial
01
Overview
Turn Therapeutics has an FDA-cleared antimicrobial ointment (Hexagen) with over 200,000 patient uses and zero reported adverse events. The company is now pursuing clinical trials for new drug indications including eczema and onychomycosis.
- Therapeutic areas
- EndocrinologyDermatologyInfectious Diseases
- Modalities
- Topical formulationsOil suspension technology
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
MiMedx (licensing deal worth up to $70M+)GEM Global Yield LLC SCS ($75M investment commitment)
04
Financials
- Market cap
- $271.5M
- Total revenue
- $0
- Enterprise value
- $267.3M
Beyond the preview
Go deeper on Turn Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Turn Therapeutics.